We examined the effects of interleukin-3 (IL-3) and interleukin-4 (IL-4) on connective tissue-type mast cells (CTMC) purified from murine peritoneal cells. Although both factors failed to induce extensive proliferation of CTMC, they stimulated CTMC proliferation synergistically in a dosedependent manner. Pretreatment of CTMC with IL-3 and/ or I L 4 indicated that the sustained presence of both factors was required for the development of type 1 mast cell colonies. The delayed addition of IL-3 to cultures of purified CTMC with IL-4 induced no colony formation, while the delayed addition of IL-4 to cultures with IL-3, even on day 28 of culture, induced type 1 colony formation. In replating type 1 colonies induced by IL-3 and IL-4 to secondary cultures with IL-3 alone, few secondary colonies HERE ARE TWO phenotypically distinct subpopula-T tions of mast cells in rodents: connective tissue-type mast cells(CTMC) and mucosal mast cells (MMC). CTMC, which are present in the skin, peritoneal cavity, and other sites, have a large cell size, contain many large granules stained with alcian blue*/safranin+/berberine sulfate+, have heparin proteoglycan and relatively large amounts of histamine, and exhibit little or no dependence on T-cell regulation. In contrast, MMC, which are prominent in the mucosal layer of the gastrointestinal tract, have a smaller cell size, contain fewer granules stained with alcian blue+/safranin-/ berberine sulfate-, have chondroitin sulfate E proteoglycan and lower amounts of histamine, and exhibit T-cell dependent pr01iferation.l.~ Several investigators have reported on mouse bone marrow-derived mast cells (BMMC) in cultures supplemented with conditioned medium from stimulated T cells or WEHI-3B cells.4.' Subsequently, it has been demonstrated that one of the biologically active factors in the conditioned medium responsible for the proliferation of BMMC is interle~kin(IL)-3.~ IL-3 has been purified to homogeneity and shown to be a glycoprotein of 28 Kd,' and the molecular cloning of complementary DNA for mouse IL-3 has been reported.*l9 BMMC are in many ways similar to MMC: they are small in diameter, possess occasionally bilobed nuclei, are stained with alcian blue but not safranin or berberine sulfate, contain chondroitin sulfate E proteoglycan rather than heparin proteogylcan, and have a relatively low histamine
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We have recently identified two different types of mast cell colonies in cultures of murine peritoneal cells in the presence of medium conditioned by pokeweed mitogen-stimulated spleen cells (PWMSCM); type 1 and type 2 colonies."
Type 1 colonies consisted of large mast cells stained with alcian blue+ /safranin+ /berberine sulfate', revealing CTMClike features, and type 2 colonies consisted of small mast cells stained with alcian blue+/safranin-/berberine sulfate-, revealing MMC-like features. Percoll density-gradient centrifugation of peritoneal cells demonstrated that cells in the heaviest density fraction, which consisted of alcian blue*/ safranin+/berberine sulfate+ CTMC, produced only type 1 colonies, and that cells in light density fractions, which consisted of lymphoid cells, produced only type 2 colonies in the presence of PWMSCM. It further indicated that type 1 colonies were derived from mature CTMC and type 2 colonies from immature progenitors in light density fractions. Although the development of type 2 colonies was induced by IL-3 alone, the development of type 1 colonies required both IL-3 and additional factor(s) present in PWMSCM. Subsequently, it has been shown that the proliferation of CTMC is induced by the synergistic action of IL-3 and IL-4 in PWMSCM." IL-4, originally described as a costimulator of B-cell proliferation,'2 has been shown to act on a number of different types of cells, such as T -~e l l s , '~ macrophages,14 and hematopoietic progenitor cells."
To date, the detailed mechanism of the effects of IL-3 and IL-4 on the development of CTMC is unclear. In the present report, we indicate that IL-3 supports the survival of CTMC in the absence of accessory cells in methylcellulose culture, and that IL-4 triggers and supports the proliferation of CTMC synergistically with IL-3.
MATERIALS AND METHODS
Preparation of cell suspension. BDF, mice were raised at the Shizuoka Laboratory Animal Center (Shizuoka, Japan) and used at 20 to 25 weeks of age. They were anesthetized by ether and then killed by decapitation. Two milliliters of a-medium (Flow Laboratories, Rockville, MD) containing 10 IU/mL of heparin and 1% bovine serum albumin (BSA Sigma Chemical Co, St Louis, MO) was injected into the peritoneal cavity, and the abdomen was massaged gently for 30 seconds. The peritoneal cavity was carefully opened, and the fluid containing peritoneal cells was aspirated with a Pasteur pipette." The peritoneal cells consisted of 2.9 f 0.1% CTMC, 56.3 2.5% lymphoid cells, 39. 9 2.1% macrophages, 0.6 0.3% eosinophils, and 0.4 * 0.1% neutrophils.
Purification of peritoneal mast cells was done using a Percoll density-gradient centrifugation methodI7 with minor modifications." Percoll (Pharmacia Fine Chemicals AB, Uppsala, Sweden) was made isotonic by the addition of l o x Hanks' solution containing 1% BSA and 200 mmol/L HEPES to 9 parts of Percoll. Continuous density gradients of Percoll were generated by centrifugation of 7 mL of Percoll solution at 23000 x g for 60 minutes at 4OC in a Tomy RS-20 FIIIS fixed rotor (Tomy Seiko Co, Tokyo, Japan). After the removal of phagocytes using carbonyl iron (GAF Co, New York, NY), the cell suspension containing 2 x 107/mL peritoneal nonphagocytic cells was layered on top of the Percoll continuous gradient and centrifuged at 500 x g for 30 minutes. Eight fractions were separated, and the individual fractions were analyzed for cellular composition. The proportion of morphologically identifiable CTMC increased in the heavier fractions. Since more than 98% of the cells in fraction 7 (21.1 13 g/mL) were CTMC, they were used for CTMC populations.
Both mouse recombinant IL-3 (rIL-3)9 and recombinant IL-4 (rIL-4)'' were produced in yeast cells at DNAX Research Institute of Molecular and Cellular Biology (Palo Alto, CA). Their activities were determined by using P cell clone, and a colorimetric assay."
One milliliter of culture mixture containing 1 x lo5 peritoneal cells or 1 x lo3 purified peritoneal mast cells, a-medium, 0.8% methylcellulose (Shinetsu Kagaku Co, Tokyo, Japan), 30% fetal bovine serum (Hyclone Laboratories, Inc, Logan, UT), 1% BSA, mol/L mercaptoethanol (Eastman Organic Chemicals, Rochester, NY), and various concentrations of rIL-3 and/or rIL-4 was plated in 35 mm Lux standard nontissue culture dishes (#5221R, Flow Laboratories)." The dishes were incubated at 37OC in a humidified atmosphere flushed with 5% CO, in air. Mast cell colonies (220 cells) were counted on day 20 of culture, and classified into two types, type 1 (CTMC-type) and type 2 (MMCtype) by morphological criteria as described." Serum-free culture was carried out using a modification'* of the technique described previously." Briefly, 1 mL of culture mixture consisted of 1 x IO3 purified peritoneal mast cells, a-medium, 9.8% methycellulose, 1 % crystallized deionized BSA (Calbiochem-Behring Corp, La Jolla, CA), mol/L mercaptoethanol, 300 pg/mL of fully iron-saturated human transferrin (approximately 98% pure; Sigma Chemical), 160 pg/mL of soybean lecithin (Sigma Chemical), 96 pg/mL of cholesterol (Nakarai Chemicals Ltd, Kyoto, Japan), and various concentrations of rIL-3 and/or rIL-4.
Peritoneal mast cells purified by Percoll density-gradient centrifugation were plated at a concentration of 1 x 103/mL in methylcellulose medium containing 100 U/mL rIL-3 in 35 mm plastic dishes. After various periods of incubation, a single mast cell was identified morphologically on an inverted microscope at x 200 magnification, lifted from the medium using a fine Pasteur pipette (with an internal diameter of about 30 pm) attached to a micromanipulator (Eanst Leitz Ltd, Wetzlar, West Germany) and transferred to the second dish. When the second dish contained both 100 U/mL rIL-3 and 50 U/mL rIL-4, they were incubated for 20 days. When the second dish contained 100 U/mL rIL-3 alone, 50
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U/mL rIL-4 was added to the dish after 14 days of incubation, and then incubated for 20 days.
Peritoneal cells ( 5 x 1o4/mL) were cultured with 100 U/mL rIL-3 and/or 50 U/mL rIL-4 for 1,3, 6, and 12 hours. After incubation, the cells were washed three times with phosphate-buffered saline (PBS), and recultured with 100 U/mL rIL-3 and/or 50 U/mL rIL-4. In this experiment, no remarkable change in cell counts was found after preincubation.
The cultures of 1 x lO'/mL purified peritoneal mast cells were prepared in methylcellulose medium containing various concentrations of rIL-3 or rIL-4, and the other factors were added to the culture on days 7, 14, 21, and 28 of culture. After the addition of these factors, the cultures were incubated and observed every 7 days.
Type 1 colonies induced by rIL-3 and rIL-4 were lifted from the methylcellulose medium using a 3 pL Eppendorf pipette (Fremont, CA) under direct microscopic vis~alization~~ on day 14 of culture, and pooled in Eppendorf microcentrifuge tubes containing 0.5 mL of PBS. After washing three times with PBS, the pooled mast cells were divided into four aliquots. Each aliquot (1 x IO3 cells/mL was cultured under the four different conditions including no factor, 100 U/mL rIL-3 alone, 50 U/mL rIL-4 alone, and 100 U/mL rIL-3 plus 50 U/mL rIL-4.
Individual mast cell colonies or single mast cells were lifted from the methylcellulose culture medium and collected in Eppendorf microcentrifuge tubes containing 0.5 mL of PBS. After washing with PBS, the samples were immediately spun in a cytocentrifuge (Cytospin; Shundon Southern, Sewickley, PA) at 70 x g for 5 minutes and were stained with May-Griinwald-Giemsa, alcian blue-safranin*' or berberine sulfate.z6 Berberine sulfate is a fluorescent dye that binds to heparin proteoglycan in granules of mouse CTMC. To confirm the specificity of berberine sulfate staining, specimens were treated either with heparinase (Heparin lyase; Seikagaku Chemical Industry Co Ltd, Tokyo, Japan) or with chondroitinase ABC (Chondroitin ABC lyase; Seikagaku) before staining.
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RESULTS
Development of type 1 colonies from peritoneal cells by IL-3 and IL-4.
When mouse peritoneal cells were cultured in methylcellulose medium containing rIL-3, few type 1 colonies were observed in the presence of u p to 200 U/mL rIL-3. However, rIL-3 supported the development of type 1 colonies dose-dependently, beginning at 6.25 U / m L rIL-3 and reaching a plateau a t 50 U / m L rIL-3, in the presence of 50 U / m L rIL-4 ( Fig 1A) . Although rIL-4 alone failed to induce type 1 colony formation at concentrations of u p to 800 U/mL, rIL-4 stimulated type 1 colony formation dosedependently, beginning a t 0.78 U/mL rIL-4 and reaching a plateau at 50 U / m L rIL-4, in the presence of 100 U / m L rIL-3 ( Fig 1B) . In contrast, rIL-3 alone supported the development of type 2 colonies dose-dependently, and the maximum number of the colonies was obtained at a concentration of 50 U / m L rIL-3 (3 + 1 colonies/l x lo5 cells).
Further, rIL-4 was incapable of stimulating the growth of type 2 colonies, and indicated no significant effects on rIL-3-dependent type 2 colony formation.
T h e synergistic effect of rIL-3 and rIL-4 on type 1 colony growth was also observed in t h e serum-free culture of CTMC A serum-free culture containing 100 U/mL rIL-3 and 50 U/mL rIL-4. In order to exclude the possibility that contaminated cells other than CTMC affect the growth of type 1 colonies from CTMC single cell cultures of CTMC were carried out. A total of 100 single CTMC were lifted using a micromanipulator and transferred to the culture dish containing 100 U/mL rIL-3 and 50 U/mL rIL-4. Forty-two of the 100 CTMC produced type 1 colonies, and the remaining 58 CTMC failed to produce colonies.
When the constituent cells of 20 type 1 colonies supported by 100 U/mL rIL-3 and 50 U/mL rIL-4 were examined cytochemically, most of the cells were stained with both safranin (99.2 0.4%) and berberine sulfate (73. were washed after stimulation with rIL-3 and/or rIL-4 and recultured with rIL-3 or rIL-4 alone, no type 1 colonies developed. In contrast, when the same washed cells were cultured with both rIL-3 and rIL-4, many type 1 colonies developed, and the number of the colonies was comparable with that cultured with 100 U/mL rIL-3 and 50 U/mL rIL-4 without pretreatment (Table 1 ). This result indicates that stimulation by IL3 and/or IL4 only in the early stages of culturing is insufficient to induce subsequent type 1 colony formation, and that the sustained presence of both IL3 and IL4 is required for extensive proliferation of CTMC. Induction of type I colony formation by delayed addition. When purified peritoneal mast cells were cultured in the presence of rIL-3 alone, there were a lot of single mast cells revealing no dengenerative signs, such as ballooning, vacuolation, or loss of refractivity, even on day 20 of culture, although few type 1 colonies were found. In contrast, in the culture without rIL-3, most mast cells revealed degenerative signs within 14 days, and more than 90% of the cells became evanescent until day 20 of culture. From these observations, we predicted that IL-3 might support the survival of CTMC in methylcellulose culture and that IL-4 might trigger and support the proliferation of CTMC synergistically with IL-3. To confirm this hypothesis, 1 x lo3 purified CTMC were plated in a culture dish containing 100 U/mL rIL-3 or 50 U/mL rIL-4, and the other factor was added on days 7, 14, 21, and 28 of culture. Control cultures for these experiments contained both factors at the initiation of culturing. The delayed addition of 100 U/mL rIL-3 to cultures containing 50 U/mL rIL-4 resulted in no type 1 colony growth on any of the days tested. In contrast, the delayed addition of 50 U/mL rIL-4 to cultures containing 100 U/mL rIL-3, even on day 28 of culture, induced type 1 colony formation. The numbers of type 1 colonies induced by the delayed additions of rIL-4 on days 7, 14, 21, and 28 of culture were 76.1%, 65.6%, 41.1%, and 32.1% of those in control cultures, respectively (Fig 2) . To further confirm the premise that IL-3 supports the survival of CTMC, purified CTMC were plated in culture dishes containing various concentrations of rIL-3 (3.13 to 200 U/mL), and the delayed additions were supplied to the cultures on days 14 and 28. In this dose-response study, delayed additions of both 100 U/mL rIL-3 and 50 U/mL rIL-4 were performed, since less than 25 U/mL rIL-3 was insufficient to induce the proliferation of CTMC synergistically with 50 U/mL rIL-4, as shown in Fig 1A. The rIL-3 dose-dependently supported the survival of CTMC, which were capable of producing colonies after the delayed addition whether the delayed addition was carried out on day 14 or 28, and the maximum number of colonies was produced in the cultures provided with concentrations of 25 to 200 U/mL rIL-3 (Fig 3) . In the examination of the constituent cells of TSUJl ET AL 20 type 1 colonies induced by the delayed addition, the mast cells were similar in cell size and in the percentage of positive cells stained with safranin or alcian blue, whenever the delayed addition was performed ( Table 2) .
A lot of single mast cells were observed in the culture of purified CTMC with 100 U/mL rIL-3 even after 4 weeks of incubation, and the number of single mast cells without degenerative signs was approximately half the CTMC initially seeded. Then, 200 single mast cells without degenerative signs were collected from the culture of purified CTMC with 100 U/mL rIL-3 every 7 days using a micromanipulator under direct microscopic visualization (the viability of the collected mast cells determined by trypan blue exclusion test was more than 90% at any time), spun in a cytocentrifuge, and stained with May-Griinwald-Giemsa and alcian bluesafranin. May-Griinwald-Giemsa staining showed that the cell size and the size of granules were similar to those of original CTMC whenever the mast cells were collected. Alcian blue-safranin staining showed that the percentage of cells stained with alcian blue or safranin was also similar to that of original CTMC. Next, the proliferative ability of single CTMC supported with 100 U/mL rIL-3 was examined. When 100 single CTMC supported with rIL-3 were recultured with 100 U/mL rIL-3 and 50 U/mL-4, more than 40% of the CTMC produced type 1 colonies, regardless of the time of replating (Table 3 ). These observations indicate that peritoneal CTMC supported by IL-3 maintained the nature Delayed addition of 50 U/mL rlL-4 was performed on cultures containing 100 U/mL rlL-3.
of original cells and their proliferative ability until day 28 of culture. Individual type 1 colonies supported by 100 U/mL rIL-3 and 50 U/mL rIL-4 were harvested, pooled, and replated in a secondary culture containing different stimuli. When the secondary culture contained both 100 U/mL rIL-3 and 50 U/mL rIL-4,362 25 secondary colonies developed from 1 x lo3 pooled mast cells. In contrast, when the secondary culture contained no factors or 50 U/mL rIL-4 alone, no secondary colonies developed, and when the secondary culture contained 100 U/mL rIL-3 alone, a few secondary colonies developed (1 2 f colonies/l x lo3 pooled mast cells). However, when 50 U/mL rIL-4 was added to the secondary culture with rIL-3 14 days after replating, many secondary colonies were observed. The number of the secondary colonies induced by the addition of rIL-4 was 45.6% (165 * 18 colonies/l x lo3 pooled cells) of the number of type 1 colonies in the secondary culture with 100 U/mL rIL-3 and 50 U/mL rIL-4. This observation further indicates that IL-3 supports the survival of CTMC in methylcellulose culture and that IL-4 triggers and supports the proliferation of CTMC synergistically with IL-3.
Delayed addition of IL-4 to serum-free culture of purifired CTMC. To exclude the possibility that humoral factors in fetal bovine serum have an effect on the survival of CTMC by IL-3, serum-free culture was carried out using purified CTMC. Purified CTMC (1 x 103/mL) produced 125 14 type 1 colonies in the serum-free culture containing both 100 U/mL rIL-3 and 50 U/mL rIL-4, although no type 1 colonies developed in the presence of either 100 U/mL rIL-3 or 50 U/mL rIL-4 alone. However, the delayed addition of 50 U/mL rIL-4 to the primary culture containing 100 U/mL rIL-3 induced type 1 colony formation. The numbers of type 1 colonies induced by the delayed additions on days 7, 14, 21, and 28 of culture were 68.0%, 59.2%, Replating of type 1 colonies.
32.8%, and 13.6% of those initiated with both 100 U/mL rIL-3 and 50 U/mL rIL-4, respectively (Table 4) .
Delayed addition of IL-4 to the culture of single CTMC. To exclude completely the effect of accessory cells on the surviving effect by IL-3, a total of 100 single CTMC were individually transferred to a culture containing 100 U/mL rIL-3, and 50 U/mL rIL-4 was added to the culture after 2 weeks of incubation. Thirty-eight of the 100 transferred single CTMC produced type 1 colonies by the delayed addition of rIL-4.
DISCUSSION
In the present study, we have demonstrated definitively that IL-3 and IL-4, but neither alone, stimulate extensive proliferation of mature CTMC, which is in agreement with a report by Hamaguchi et al." IL-3 supported type 1 colony formation dose-dependently in the presence of IL-4. Type 1 colony formation was first observed at 6.25 U/mL IL-3 and reached a plateau at 50 U/mL IL-3 in the presence of 50 U/mL IL-4 ( Fig 1A) . IL-4 also supported type 1 colony formation dose-dependently in the presence of IL-3. Type 1 colony formation was first observed at 0.78 U/mL IL-4 and reached a plateau at 50 U/mL IL-4 in the presence of 100 U/mL IL-3 ( Fig 1B) . Pretreatment of CTMC with IL-3 and/or IL-4 indicated that the sustained presence of both IL-3 and IL-4 was required for extensive proliferation of CTMC ( Table 1 ). The culture of single CTMC and serumfree culture of purified CTMC demonstrated that the synergistic action of IL-3 and IL-4 on the proliferation of CTMC required no effects of accessory cells or other humoral factors.
The delayed addition of IL-3 to the culture with IL-4 on day 7 of culture induced no type 1 colony formation, while the delayed addition of IL-4 to the culture with IL-3, even on day 28, induced type 1 colony formation (Fig 2) . The number of type 1 colonies induced by the delayed addition revealed a *Values show the number of CTMC that produced secondary colonies when 100 single CTMC were transferred to secondary cultures containing 100 U/mL rlL-3 and 50 U/mL rlL-4. 50 U/mL rlL-4 was added to the culture containing 100 U/mL rlL-3.
dose-dependent increase to IL-3 contained in the primary culture (Fig 3) . In the delayed addition experiment, the number of type 1 colonies induced by the delayed additions decreased time-dependently. It is unclear whether this observation shows an essential effect of IL-3, or whether the result is in part due to decreased nutrition, since the number of type 1 colonies induced by the delayed additions was smaller in the serum-free culture than in the serum-containing culture ( Table 4) . Examination of the constituent mast cells of type 1 colonies induced by the delayed addition showed CTMC-like features (Table 2 ). These observations indicate that IL-3 supports the survival of CTMC in methylcellulose culture and that IL-4 triggers and supports the proliferation of CTMC synergistically with IL-3. The results of the replating experiment of type 1 colonies induced by IL-3 and IL-4 further support this. When the pooled mast cells from type 1 colonies induced by IL-3 and IL-4 were replated to cultures with IL-3 alone, few secondary colonies developed, although replating to cultures with IL-3 and IL-4 induced secondary colony formation. However, when IL-4 was added to the secondary culture with IL-3 alone 2 weeks after replating, many secondary colonies were observed. The delayed addition of IL-4 to the serum-free culture of purified CTMC and the culture of single CTMC in the presence of IL-3 also induced type 1 colony formation. These results indicate that the surviving effect of IL-3 on CTMC also requires no effects of accessory cells or other humoral factors.
To confirm the surviving effect of IL-3 on CTMC, single peritoneal mast cells supported with IL-3 were lifted from the culture medium and examined. Morphological and cytochemical examination showed that they were similar to original peritoneal mast cells in cell size, size of granules, and staining characteristics, revealing properties of CTMC. In addition, when they were transferred to the culture containing IL-3 and IL-4, they produced type 1 colonies (Table 3 ). These observations indicate that CTMC supported with IL-3 preserve not only the morphological and cytochemical characteristics of CTMC, but also the ability to respond to the simultaneous stimulation of IL-3 and IL-4 to proliferate.
Levi-Schaffer et aI2' demonstrated that rat CTMC were maintained for as long as 30 days when cocultured with mouse skin-derived 3T3 fibroblasts. In their report, they observed that the CTMC were maintained but did not divide, and speculated that mast cells, which differentiated to synthesize heparin, might lose their proliferative ability. Nakano et a128 recently demonstrated that the acquisition of CTMC-like characteristics in mouse BMMC transferred to the peritoneal cavity was associated with proliferation arrest. These reports suggest a relationship between the phenotypical character of mast cells and their proliferative stage. The difference in staining characteristics between mast cells composing type 1 colonies and single CTMC supported with IL-3, observed in this study, may support this suggestion. The former revealed a higher percentage of cells stained with alcian blue than did the latter. In addition, a quarter of the constituent mast cells of type 1 colonies were not stained with berberine sulfate. These observations suggest that CTMC that enter the proliferative phase may gradually lose their CTMC-like character and acquire an MMC-like character. Furthermore, when the constituent mast cells of type 1 colonies induced by IL-3 and IL-4 were replated to the secondary culture containing IL-3 alone, they produced a few secondary colonies. This suggests that CTMC in proliferative states may graduallly acquire not only morphological and cytochemical characteristics of MMC, but also the ability to proliferate IL-34ependently. Our culture systems containing IL-3 for the maintenance of CTMC may be useful for examining the effects of factors on the proliferation and/or the phenotypic changes of CTMC.
